Table 1_Multi-targeted protection of Yuping Tongqiao against allergic rhinitis: suppressio

A research study investigating the therapeutic efficacy and mechanisms of Yuping Tongqiao Tablet (YPTQ) against allergic rhinitis. The dataset, authored by Zhixin Wang and last updated in May 2026, contains results from in vivo rat models and in vitro human nasal epithelial cell models, integrated with network pharmacology and molecular docking analyses. It is a 16.9 KB document shared under a CC-BY-4.0 license on figshare.

Use Cases

• Validate therapeutic mechanisms of traditional Chinese medicine based on described TSLP and AhR signaling pathways.
• Analyze the relationship between inflammatory cytokines and barrier proteins based on the described in vitro cell model results.
• Identify potential drug targets for allergic rhinitis based on the integrated network pharmacology and molecular docking analysis mentioned in the description.
• Study the effects of the active ingredient kaempferol based on its described role in the dual-pathway mechanism.

Strengths

• Includes integrated validation from both in vivo rat models and in vitro human cell models, as described.
• Employs a multi-method approach combining network pharmacology and molecular docking with experimental validation.
• Shared under a permissive CC-BY-4.0 license, allowing for reuse and redistribution.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small at 16.9 KB, indicating limited scope, likely containing only the research document.

Provenance

Source

figshare

Collection Method

Experimental research involving animal models, cell cultures, and computational analysis.

Time Range

Study period not specified; dataset metadata updated in 2026.

Freshness

Last updated 2026-05-08 05:44:03; freshness should be verified.

Geography

Geographic scope of the research is not specified.